A&P - Glaucoma MKS

-

Glaucoma - Glaucoma Suspect

POAG suspect based on ______. 
IOP lowering treatment is not indicated at this time; continue to monitor condition as directed. RTC for special testing to rule out glaucoma progression. 

Edu pt on exam findings. Advised pt on risk of vision loss associated with glaucoma & need for treatment & testing compliance.


Glaucoma Continue Treatment

Pt is meeting target IOP in office today - see chart notes for more details. Continue treatment with topical IOP lowering medication as directed. RTC for special glaucoma testing as directed. 

Edu pt on exam findings. Advised pt on risk of vision loss associated with glaucoma & need for treatment compliance. 


Glaucoma Initiate Treatment

Pt's IOP measurements are above ideal target pressure - see chart notes for more details. Initiate treatment with topical IOP lowering medication as directed. RTC for special glaucoma testing as directed.

Edu pt on exam findings. Advised pt on risk of vision loss associated with glaucoma & need for treatment compliance. 



Glaucoma - Severe Stage Referral Statement

Edu pt that she has the option to be managed by OMD (glaucoma specialist) by law due to severe staging of glaucoma. Pt declined and would like to continue care with us. Pt understands risks, benefits, and potential adverse events associated with condition and treatment options. Pt denied, pt wants to continue care at current clinic.

Edu pt on exam findings. Advised pt on risk of vision loss associated with glaucoma & need for treatment compliance.
Edu pt on driving restrictions due to severe staging of glaucoma. Pt understood all instructions.


Glaucoma - Surgical Referral

Pt is not meeting target IOP pressures in office today - see chart notes for more details. SLT surgery indicated at this time - refer pt to ophthalmologist specializing in glaucoma for consult and procedure. Risks and benefits of surgical procedure were discussed with pt in office. Instructed pt to continue using topical IOP lowering medications as prescribed. RTC for special glaucoma testing as directed.

Edu pt on exam findings. Advised pt on risk of vision loss associated with glaucoma & need for treatment compliance.




Comments

Post a Comment

Popular posts from this blog

Understanding Insurance (Copay vs. Coinsurance)

-
  If they have not met their deductible, then you look at their copay (if they have both copay and coinsurnace). But if they have met detuctible  then look at coinsurnace.  If they don’t have copay, then look at detuctible, If they haven’t met, then pay the $90 (our office). If met, pay the coinsurnace percentage. 
Read more

Color Vision Glasses, Color Blind Glasses

-
  https://www. glassesforthecolorblind.com/ resellers-order for patient - this is where you would order from ^^ the above link order the dark purple one    COLOR : PU-1 (we have this one in the office that the pt can try and see if they like it) No login is needed, there's a spot on the website where you can place the order. Pt has option of doing clip on vs. making glasses that are purple in  color  - cost is similar but pt may want to do clip on instead since they may not want purple looking glasses to wear full time. cost ranges from $200 to $300 - similar cost for the clip and the glasses. On rev, if you go to inventory--> products --> then type in the search "colormyglasses" you can see all the different options --- Order the purple one PU-1: works for most color vision problems
Read more

Recurrent Subconj Heme Testing & attached letter to PCP

-
  Laboratory testing may be directed toward identifying blood dyscrasias, clotting disorders and other hematological abnormalities. Suggested testing may include (but is not limited to) the following:  ●        Complete blood count with platelets (CBC with differential and platelets) ●        CMB - comprehensive metabolic panel ●        Prothrombin time (PT) ●        Activated partial thromboplastin time (PTT) ●        Activated partial thromboplastin time (APTT)  ●        An international ratio (INR) to rule out over-anticoagulation in patients taking blood thinners ●        Antiphospholipid antibodies ●        Homocysteine level, particularly in young men ●        Assay for natural anticoagulants such as protein S and protein C, antithrombin III, factor V Leiden ●        Beta-glycoprotein ●        HIV Virus titers ●        Anticoagulation panel for lupus if suspected autoimmune condition ●        Sjogren’s testing panel ●        If African American, sickle cell panel ●        Patient
Read more